Multitasking of Neuropeptide Y through the Lens of Motifs

Myslobodsky, Michael
January 2009
Recent Patents on CNS Drug Discovery;Jan2009, Vol. 4 Issue 1, p52
Academic Journal
Networks controlling ingestion-related peptides are also known to be the targets and signals for numerous other systems. Yet, their topological properties are still ill understood. The Ingenuity Pathway Analysis (IPA) was employed to represent molecules engaged in feeding as nodes, and the interactions between them as edges. Using extracted molecules as 'seeds' for core analysis it was possible to scrutinize some of the complex relationships of sub-networks and the socalled 'motifs' well outside the neighborhoods of their classical roles. Contrary to the requirements for modular structure, the orexigenic and anorexigenic neuropeptides do not represent two types of modules. They are densely interconnected. Functional annotations showed that the same molecules are recruited ad-hoc from a larger 'repository' and assembled into dynamic networks for executing diverse physiological functions and behaviors. Some molecules clustered in motifs appear as the multipurpose entities for cell-to-cell signaling, organismal development, cellular movement, growth and proliferation, endocrine system development and tissue morphology, etc. that apparently become active in early ontogeny. Based mostly on neuropeptide Y (NPY), my arguments here will focus on the potential benefits of exploring motifs in network controlling ingestion for generating insights for polypharmacy of obesity-related targets and co-morbid disorders. Recent patents describing new NPY receptor antagonists directed to treat obesity and cardiovascular disorders were cited.


Related Articles

  • NPY and NPY Receptors in Vascular Remodeling. Abe, Ken; Tilan, Jason U.; Zukowska, Zofia // Current Topics in Medicinal Chemistry;Sep2007, Vol. 7 Issue 17, p1704 

    Neuropeptide Y (NPY) is a sympathetic neurotransmitter that acts on multiple receptors (Y1-Y6) and exerts a variety of cardiovascular effects. Originally known as a vasoconstrictor acting on Y1 receptors, NPY is also a potent angiogenic factor as well as a powerful stimulator of vascular smooth...

  • Y2Y4 Receptor Double Knockout Protects Against Obesity Due to a High-Fat Diet or Y1 Receptor Deficiency in Mice. Sainsbury, Amanda; Bergen, Hugo T.; Boey, Dana; Bamming, Darja; Cooney, Gregory J.; Shu Lin; Couzens, Michelle; Stroth, Nikolas; Lee, Nicola J.; Lindner, Diana; Singewald, Nicolas; Karl, Tim; Duffy, Liesl; Enriquez, Ronaldo; Slack, Katy; Sperk, Günther; Herzog, Herbert // Diabetes;Jan2006, Vol. 55 Issue 1, p19 

    Neuropeptide Y receptors are critical regulators of energy homeostasis, but the functional interactions and relative contributions of Y receptors and the environment in this process are unknown. We measured the effects of an ad libitum diet of normal or high-fat food on energy balance in mice...

  • Prime time for neuropeptide Y. Howlett, Rory // Nature;7/11/1996, Vol. 382 Issue 6587, p113 

    Reports that attention has switched to neuropeptide Y (NPY), a hormone known to increase food intake when injected into the central nervous system. Role of NPY in the feeding pathway.

  • A receptor subtype involved in neuropeptide-Y-induced food intake. Gerald, Christophe; Walker, Mary W. // Nature;7/11/1996, Vol. 382 Issue 6587, p168 

    Reports that neuropeptide is a powerful stimulant of food intake and is proposed to activate a hypothalamic `feeding' receptor. Expression cloning of a novel Y-type receptor from rat hypothalamus; Presence of the messenger RNA in the central nervous system of the hypothalamus; Extent to which...

  • Newest on the anti-obesity war: The `no-more-overeating' pill? Doheny, Kathleen; Howard, Beth // Shape;Feb97, Vol. 16 Issue 6, p24 

    Reports on the discovery of the neuropeptide Y 5 receptor. Market timetable for a miracle pill; Prospects of an anti-obesity drug development.

  • Corrigenda: Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Kuo, Lydia E; Kitlinska, Joanna B; Tilan, Jason U; Li, Lijun; Baker, Stephen B; Johnson, Michael D; Lee, Edward W; Burnett, Mary Susan; Fricke, Stanley T; Kvetnansky, Richard; Herzog, Herbert; Zukowska, Zofia // Nature Medicine;Sep2007, Vol. 13 Issue 9, p1120 

    A correction to the article "Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome," that was published in the July 1, 2007 is presented.

  • Neuropeptide Y (NPY) and NPY receptors in the cardiovascular system: implication in the regulation of intracellular calcium. Jacques, Danielle; Abdel-Samad, Dima // Canadian Journal of Physiology & Pharmacology;Jan2007, Vol. 85 Issue 1, p43 

    The 3-dimensional confocal microscopy technique has allowed us to identify the presence of yet another cardioactive factor and its receptor, namely neuropeptide Y (NPY) and its Y1 receptor, at the level of vascular smooth muscle cells and heart cells including endocardial endothelial cells...

  • Endogenous Kisspeptin Tone Is a Critical Excitatory Component of Spontaneous GnRH Activity and the GnRH Response to NPY and CART. Verma, Saurabh; Kirigiti, Melissa a.; Millar, Robert P.; Grove, Kevin L.; Smith, M. Susan // Neuroendocrinology;Oct2014, Vol. 99 Issue 3/4, p190 

    Background/Aims: Kisspeptin is the major excitatory regulator of gonadotropin-releasing hormone (GnRH) neurons and is responsible for basal GnRH/LH release and the GnRH/LH surge. Although it is widely assumed, based on mutations in kisspeptin and Kiss1R, that kisspeptin acts to sustain basal...

  • Moderate Caloric Restriction during Gestation in Rats Alters Adipose Tissue Sympathetic Innervation and Later Adiposity in Offspring. García, Ana Paula; Palou, Mariona; Sánchez, Juana; Priego, Teresa; Palou, Andreu; Picó, Catalina // PLoS ONE;2011, Vol. 6 Issue 2, p1 

    Maternal prenatal undernutrition predisposes offspring to higher adiposity in adulthood. Mechanisms involved in these programming effects, apart from those described in central nervous system development, have not been established. Here we aimed to evaluate whether moderate caloric restriction...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics